{"id":417719,"date":"2021-01-20T08:33:17","date_gmt":"2021-01-20T13:33:17","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=417719"},"modified":"2021-01-20T08:33:17","modified_gmt":"2021-01-20T13:33:17","slug":"ligands-fourth-quarter-financial-results-to-be-reported-february-3rd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/","title":{"rendered":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwnowrap { white-space: nowrap }\n.bwpadl0 { padding-left: 0px }\n.bwtablemarginb { margin-bottom: 10px }\n.bwvertalignt { vertical-align: top }\n.bwwidth16 { width: 16% }\n.bwwidth84 { width: 84% }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3<sup>rd<\/sup><\/b><\/p>\n<p>SAN DIEGO&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<b>Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) <\/b>provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand\u2019s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call.\n<\/p>\n<p><b>Fourth Quarter 2020 Earnings Conference Call<\/b><\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\" style=\"width:784px\">\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nWhat:\n<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nLigand conference call to discuss financial results and provide general business updates\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nDate:\n<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nWednesday, February 3, 2021\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nTime:\n<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n8:30 a.m. Eastern time (5:30 a.m. Pacific time)\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwnowrap bwwidth16\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nConference Call:\n<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nDial (833) 540-1167 within the U.S.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nDial (929) 517-0358 outside the U.S.\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nConference ID is 6081598\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\" \/>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n\u00a0\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwwidth16\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nWebcast:\n<\/p>\n<\/td>\n<td class=\"bwvertalignt bwpadl0 bwwidth84\" style=\"width:675px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nLive conference call webcast and replay accessible at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ligand.com&amp;esheet=52364113&amp;newsitemid=20210120005045&amp;lan=en-US&amp;anchor=www.ligand.com&amp;index=1&amp;md5=ae0405e2ac6c1d8895c84b465cc61d17\">www.ligand.com<\/a><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p><b>About Ligand Pharmaceuticals<\/b><\/p>\n<p>\nLigand is a revenue-generating biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand\u2019s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand\u2019s goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand\u2019s business model is based on doing what Ligand does best: drug discovery, early-stage drug development, product reformulation and partnering. Ligand partners with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. Ligand\u2019s OmniAb<sup>\u00ae<\/sup> technology platform is a patent-protected transgenic animal platform used in the discovery of fully human mono- and bispecific therapeutic antibodies. The Captisol<sup>\u00ae<\/sup> platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Ligand\u2019s Protein Expression Technology<sup>\u00ae<\/sup> is a robust, validated, cost-effective and scalable approach to recombinant protein production, and is especially well-suited for complex, large-scale protein production that cannot be made by more traditional systems. Ab Initio<sup>\u2122<\/sup> technology and services for the design and preparation of customized antigens enable the successful discovery of therapeutic antibodies against difficult-to-access cellular targets. Ligand has established multiple alliances, licenses and other business relationships with the world\u2019s leading pharmaceutical companies including Amgen, Merck, Pfizer, Roche, Sanofi, Janssen, Takeda, Gilead Sciences, GSK and Baxter International. For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ligand.com&amp;esheet=52364113&amp;newsitemid=20210120005045&amp;lan=en-US&amp;anchor=www.ligand.com&amp;index=2&amp;md5=803517202c49f36f92623225dbe5bf04\">www.ligand.com<\/a>.\n<\/p>\n<p>\nFollow Ligand on Twitter @Ligand_LGND.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210120005045\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210120005045\/en\/<\/a><\/span><\/p>\n<p>\nLigand Pharmaceuticals Incorporated<br \/>\n<br \/>Patrick O\u2019Brien<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:investors@ligand.com\">investors@ligand.com<br \/>\n<\/a><br \/>(858) 550-7893\n<\/p>\n<p>\nLHA Investor Relations<br \/>\n<br \/>Bruce Voss<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:bvoss@lhai.com\">bvoss@lhai.com<br \/>\n<\/a><br \/>(310) 691-7100\n<\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210120005045\/en\/346436\/3\/Ligand-Logo-Registered5.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand\u2019s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. Fourth Quarter 2020 Earnings Conference Call What: Ligand conference call to discuss financial results and provide general business updates \u00a0 Date: Wednesday, February 3, 2021 \u00a0 Time: 8:30 a.m. Eastern time (5:30 a.m. Pacific time) \u00a0 Conference Call: Dial (833) 540-1167 within the U.S. Dial (929) 517-0358 outside the U.S. Conference ID is 6081598 \u00a0 Webcast: Live conference call webcast and replay accessible at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-417719","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand\u2019s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. Fourth Quarter 2020 Earnings Conference Call What: Ligand conference call to discuss financial results and provide general business updates \u00a0 Date: Wednesday, February 3, 2021 \u00a0 Time: 8:30 a.m. Eastern time (5:30 a.m. Pacific time) \u00a0 Conference Call: Dial (833) 540-1167 within the U.S. Dial (929) 517-0358 outside the U.S. Conference ID is 6081598 \u00a0 Webcast: Live conference call webcast and replay accessible at &hellip; Continue reading &quot;Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T13:33:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd\",\"datePublished\":\"2021-01-20T13:33:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/\"},\"wordCount\":448,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/\",\"name\":\"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-20T13:33:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/","og_locale":"en_US","og_type":"article","og_title":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk","og_description":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand\u2019s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. Fourth Quarter 2020 Earnings Conference Call What: Ligand conference call to discuss financial results and provide general business updates \u00a0 Date: Wednesday, February 3, 2021 \u00a0 Time: 8:30 a.m. Eastern time (5:30 a.m. Pacific time) \u00a0 Conference Call: Dial (833) 540-1167 within the U.S. Dial (929) 517-0358 outside the U.S. Conference ID is 6081598 \u00a0 Webcast: Live conference call webcast and replay accessible at &hellip; Continue reading \"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T13:33:17+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd","datePublished":"2021-01-20T13:33:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/"},"wordCount":448,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/","name":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-20T13:33:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005045r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ligands-fourth-quarter-financial-results-to-be-reported-february-3rd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ligand\u2019s Fourth Quarter Financial Results to be Reported February 3rd"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=417719"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/417719\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=417719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=417719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=417719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}